<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39335496</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Decreased Protein C Pathway Activity in COVID-19 Compared to Non-COVID Sepsis: An Observational and Comparative Cohort Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1982</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12091982</ELocationID><Abstract><AbstractText>Sepsis-associated coagulopathy increases risk of mortality. Impairment of the anticoagulant protein C (PC) pathway may contribute to the thrombotic phenotype in coronavirus disease 2019 (COVID-19) sepsis. This study assessed the functionality of this pathway in COVID-19 and non-COVID sepsis by measuring its key enzymes, thrombin and activated PC (APC). The study population included 30 patients with COVID-19, 47 patients with non-COVID sepsis, and 40 healthy controls. In healthy controls, coagulation activation and subsequent APC formation was induced by 15 µg/kg recombinant activated factor VII one hour before blood sampling. APC and thrombin in plasma were measured using oligonucleotide-based enzyme capture assays. The indirect thrombin markers prothrombin-fragment 1+2 (F1+2) and thrombin-antithrombin complex (TAT) were also measured. Compared with stimulated healthy controls, median thrombin, F1+2, and TAT levels were higher in patients with COVID-19 (up to 6-fold, <i>p</i> &lt; 2 × 10<sup>-6</sup>) and non-COVID sepsis (up to 4.7-fold, <i>p</i> &lt; 0.010). APC levels were 2.4-fold higher in patients with COVID-19 (7.44 pmol/L, <i>p</i> = 0.011) and 3.4-fold higher in non-COVID sepsis patients (10.45 pmol/L, <i>p</i> = 2 × 10<sup>-4</sup>) than in controls (3.08 pmol/L). Thrombin markers and APC showed correlation in both COVID-19 (r = 0.364-0.661) and non-COVID sepsis patients (r = 0.535-0.711). After adjustment for PC levels, median APC/thrombin, APC/F1+2, and APC/TAT ratios were 2-fold (<i>p</i> = 0.036), 6-fold (<i>p</i> = 3 × 10<sup>-7</sup>) and 3-fold (<i>p</i> = 8 × 10<sup>-4</sup>) lower in the COVID-19 group than in the non-COVID sepsis group, and the latter two were also lower in the COVID-19 group than in stimulated healthy controls. In conclusion, it was found that a comparatively lower anticoagulant APC response in COVID-19 patients as compared to non-COVID sepsis patients, potentially linked to endothelial dysfunction, contributes to the prothrombotic phenotype of COVID-19 sepsis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rühl</LastName><ForeName>Heiko</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0672-2453</Identifier><AffiliationInfo><Affiliation>Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bode</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0830-870X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becher</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>First Department of Medicine, University Medical Centre Mannheim, Faculty of Medicine Mannheim, University of Heidelberg, 68167 Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckert</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohsen</LastName><ForeName>Ghaith</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McRae</LastName><ForeName>Hannah L</ForeName><Initials>HL</Initials><Identifier Source="ORCID">0000-0001-5216-6270</Identifier><AffiliationInfo><Affiliation>Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Müller</LastName><ForeName>Jens</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7713-9631</Identifier><AffiliationInfo><Affiliation>Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reda</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loßnitzer</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oldenburg</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1585-4100</Identifier><AffiliationInfo><Affiliation>Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putensen</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pötzsch</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>COVIMMUNE/01KI20343</GrantID><Agency>Bundesministerium für Bildung und Forschung</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">protein C</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">thrombin</Keyword><Keyword MajorTopicYN="N">thrombophilia</Keyword></KeywordList><CoiStatement>B.P. and J.M. have patents DE102007041476 and DE102007063902B3 including the previously described aptamer HD1-22 binding to thrombin and the aptamer HS02-52G binding to APC. An assay for the quantification of APC levels in human plasma, based on this aptamer, has been licensed to ImmBioMed, Pfungstadt, Germany. J.O. has received research funding from Bayer, Biotest, CSL Behring, Octapharma, Pfizer, Swedish Orphan Biovitrum, and Takeda; consultancy, speakers bureau, honoraria, scientific advisory board, and travel expenses from Bayer, Biogen Idec, BioMarin, Biotest, Chugai Pharmaceutical Co., Ltd., CSL Behring, Freeline, Grifols, LFB, Novo Nordisk, Octapharma, Pfizer, F. Hoffmann-La Roche Ltd., Sanofi, Spark Therapeutics, Swedish Orphan Biovitrum, and Takeda. The other authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39335496</ArticleId><ArticleId IdType="pmc">PMC11444193</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12091982</ArticleId><ArticleId IdType="pii">biomedicines12091982</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.-D., Coopersmith C.M., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801–810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., van der Poll T. Coagulation and sepsis. Thromb. Res. 2016;149:38–44. doi: 10.1016/j.thromres.2016.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2016.11.007</ArticleId><ArticleId IdType="pubmed">27886531</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode C., Weis S., Sauer A., Wendel-Garcia P., David S. Targeting the host response in sepsis: Current approaches and future evidence. Crit. Care. 2023;27:478. doi: 10.1186/s13054-023-04762-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04762-6</ArticleId><ArticleId IdType="pmc">PMC10698949</ArticleId><ArticleId IdType="pubmed">38057824</ArticleId></ArticleIdList></Reference><Reference><Citation>Gando S., Levi M., Toh C.-H. Disseminated intravascular coagulation. Nat. Rev. Dis. Prim. 2016;2:16037. doi: 10.1038/nrdp.2016.37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.37</ArticleId><ArticleId IdType="pubmed">27250996</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., Poll T. Coagulation in Patients with Severe Sepsis. Semin. Thromb. Hemost. 2015;41:009–015. doi: 10.1055/s-0034-1398376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1398376</ArticleId><ArticleId IdType="pubmed">25590524</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouck E.G., Denorme F., Holle L.A., Middelton E.A., Blair A.M., de Laat B., Schiffman J.D., Yost C.C., Rondina M.T., Wolberg A.S., et al. COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity. Arter. Thromb. Vasc. Biol. 2020;41:401–414. doi: 10.1161/ATVBAHA.120.315338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315338</ArticleId><ArticleId IdType="pmc">PMC7942774</ArticleId><ArticleId IdType="pubmed">33196292</ArticleId></ArticleIdList></Reference><Reference><Citation>Juneja G.K., Castelo M., Yeh C.H., Cerroni S.E., Hansen B.E., Chessum J.E., Abraham J., Cani E., Dwivedi D.J., Fraser D.D., et al. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study. J. Thromb. Haemost. 2021;19:1546–1557. doi: 10.1111/jth.15327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15327</ArticleId><ArticleId IdType="pmc">PMC8250276</ArticleId><ArticleId IdType="pubmed">33826233</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardaway R.M., Williams C.H., Vasquez Y. Disseminated Intravascular Coagulation in Sepsis. Semin. Thromb. Hemost. 2001;27:577–584. doi: 10.1055/s-2001-18863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2001-18863</ArticleId><ArticleId IdType="pubmed">11740681</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Esmon N.L., Esmon C.T. Reconstitution of the Human Endothelial Cell Protein C Receptor with Thrombomodulin in Phosphatidylcholine Vesicles Enhances Protein C Activation. J. Biol. Chem. 1999;274:6704–6710. doi: 10.1074/jbc.274.10.6704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.10.6704</ArticleId><ArticleId IdType="pubmed">10037768</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin J.H., Zlokovic B.V., Mosnier L.O. Activated protein C, protease activated receptor 1, and neuroprotection. Blood. 2018;132:159–169. doi: 10.1182/blood-2018-02-769026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-02-769026</ArticleId><ArticleId IdType="pmc">PMC6043978</ArticleId><ArticleId IdType="pubmed">29866816</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway E.M., Mackman N., Warren R.Q., Wolberg A.S., Mosnier L.O., Campbell R.A., Gralinski L.E., Rondina M.T., van de Veerdonk F.L., Hoffmeister K.M., et al. Understanding COVID-19-associated coagulopathy. Nat. Rev. Immunol. 2022;22:639–649. doi: 10.1038/s41577-022-00762-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00762-9</ArticleId><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanne T.M., Pedersen A., Gisslén M., Jern C. Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19. Thromb. Res. 2021;204:13–15. doi: 10.1016/j.thromres.2021.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.05.016</ArticleId><ArticleId IdType="pmc">PMC8163729</ArticleId><ArticleId IdType="pubmed">34102452</ArticleId></ArticleIdList></Reference><Reference><Citation>Mast A.E., Wolberg A.S., Gailani D., Garvin M.R., Alvarez C., Miller J.I., Aronow B., Jacobson D. SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung. eLife. 2021;10:e64330. doi: 10.7554/eLife.64330.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64330</ArticleId><ArticleId IdType="pmc">PMC8049742</ArticleId><ArticleId IdType="pubmed">33683204</ArticleId></ArticleIdList></Reference><Reference><Citation>Francischetti I.M., Toomer K., Zhang Y., Jani J., Siddiqui Z., Brotman D.J., Hooper J.E., Kickler T.S. Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection. eClinicalMedicine. 2021;39:101069. doi: 10.1016/j.eclinm.2021.101069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101069</ArticleId><ArticleId IdType="pmc">PMC8342934</ArticleId><ArticleId IdType="pubmed">34377969</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayrakci N., Ozkan G., Mutlu L.C., Erdem L., Yildirim I., Gulen D., Celikkol A. Relationship between serum soluble en-dothelial protein C receptor level and COVID-19 findings. Blood Coagul. Fibrinolysis. 2021;32:550–555. doi: 10.1097/MBC.0000000000001070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0000000000001070</ArticleId><ArticleId IdType="pmc">PMC8630928</ArticleId><ArticleId IdType="pubmed">34321403</ArticleId></ArticleIdList></Reference><Reference><Citation>Won T., Wood M.K., Hughes D.M., Talor M.V., Ma Z., Schneider J., Skinner J.T., Asady B., Goerlich E., Halushka M.K., et al. Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs. EBioMedicine. 2022;75:103812. doi: 10.1016/j.ebiom.2022.103812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103812</ArticleId><ArticleId IdType="pmc">PMC8756077</ArticleId><ArticleId IdType="pubmed">35033854</ArticleId></ArticleIdList></Reference><Reference><Citation>Becher T., Müller J., Akin I., Baumann S., Bosch K., Stach K., Borggrefe M., Pötzsch B., Loßnitzer D. The evolution of activated protein C plasma levels in septic shock and its association with mortality: A prospective observational study. J. Crit. Care. 2018;47:41–48. doi: 10.1016/j.jcrc.2018.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2018.06.003</ArticleId><ArticleId IdType="pubmed">29886066</ArticleId></ArticleIdList></Reference><Reference><Citation>Becher T., Müller J., Akin I., Baumann S., Stach K., Borggrefe M., Pötzsch B., Loßnitzer D. Characterization of circulating thrombin in patients with septic shock: A prospective observational study. J. Thromb. Thrombolysis. 2019;50:90–97. doi: 10.1007/s11239-019-01992-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-019-01992-w</ArticleId><ArticleId IdType="pubmed">31722081</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuppert A., Polotzek K., Schmitt J., Busse R., Karschau J., Karagiannidis C. Different spreading dynamics througout Germany during the second wave of the COVID-19 pandemic: A time series study based on national surveillance data. Lancet Reg. Health–Eur. 2021;6:100151. doi: 10.1016/j.lanepe.2021.100151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100151</ArticleId><ArticleId IdType="pmc">PMC8454815</ArticleId><ArticleId IdType="pubmed">34557834</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., Sevransky J.E., Sprung C.L., Douglas I.S., Jaeschke R., et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med. 2013;41:165–228. doi: 10.1007/s00134-012-2769-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2769-8</ArticleId><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Müller J., Becher T., Braunstein J., Berdel P., Gravius S., Rohrbach F., Oldenburg J., Mayer G., Pötzsch B. Profiling of Active Thrombin in Human Blood by Supramolecular Complexes. Angew. Chem. Int. Ed. 2011;50:6075–6078. doi: 10.1002/anie.201007032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201007032</ArticleId><ArticleId IdType="pubmed">21591028</ArticleId></ArticleIdList></Reference><Reference><Citation>Müller J., Friedrich M., Becher T., Braunstein J., Kupper T., Berdel P., Gravius S., Rohrbach F., Oldenburg J., Mayer G., et al. Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide-based enzyme capture assay. J. Thromb. Haemost. 2012;10:390–398. doi: 10.1111/j.1538-7836.2012.04623.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2012.04623.x</ArticleId><ArticleId IdType="pubmed">22236082</ArticleId></ArticleIdList></Reference><Reference><Citation>Billoir P., Leprêtre P., Thill C., Bellien J., Duchez V.L.C., Selim J., Tamion F., Clavier T., Besnier E. Routine and Advanced Laboratory Tests for Hemostasis Disorders in COVID-19 Patients: A Prospective Cohort Study. J. Clin. Med. 2022;11:1383. doi: 10.3390/jcm11051383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11051383</ArticleId><ArticleId IdType="pmc">PMC8911406</ArticleId><ArticleId IdType="pubmed">35268474</ArticleId></ArticleIdList></Reference><Reference><Citation>Hvas C.L., Larsen J.B., Adelborg K., Christensen S., Hvas A.-M. Dynamic Hemostasis and Fibrinolysis Assays in Intensive Care COVID-19 Patients and Association with Thrombosis and Bleeding—A Systematic Review and a Cohort Study. Semin. Thromb. Hemost. 2021;48:031–054. doi: 10.1055/s-0041-1735454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1735454</ArticleId><ArticleId IdType="pubmed">34715692</ArticleId></ArticleIdList></Reference><Reference><Citation>Rühl H., Berens C., Winterhagen F.I., Reda S., Müller J., Oldenburg J., Pötzsch B. Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G&gt;A Carriers. Circ. Res. 2019;125:523–534. doi: 10.1161/CIRCRESAHA.119.315037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.119.315037</ArticleId><ArticleId IdType="pubmed">31314700</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaumenhaft R., Enjyoji K., Schmaier A.A. Vasculopathy in COVID-19. Blood. 2022;140:222–235. doi: 10.1182/blood.2021012250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021012250</ArticleId><ArticleId IdType="pmc">PMC8736280</ArticleId><ArticleId IdType="pubmed">34986238</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A., Vecchié A., Dagna L., Martinod K., Dixon D.L., Van Tassell B.W., Dentali F., Montecucco F., Massberg S., Levi M., et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 2021;21:319–329. doi: 10.1038/s41577-021-00536-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Renzi S., Landoni G., Zangrillo A., Ciceri F. MicroCLOTS pathophysiology in coronavirus disease 2019. Korean J. Intern. Med. 2020;38:570–571. doi: 10.3904/kjim.2020.336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2020.336</ArticleId><ArticleId IdType="pmc">PMC10338241</ArticleId><ArticleId IdType="pubmed">32972126</ArticleId></ArticleIdList></Reference><Reference><Citation>Meini S., Zanichelli A., Sbrojavacca R., Iuri F., Roberts A.T., Suffritti C., Tascini C. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key? Front. Immunol. 2020;11:2014. doi: 10.3389/fimmu.2020.02014.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.02014</ArticleId><ArticleId IdType="pmc">PMC7432138</ArticleId><ArticleId IdType="pubmed">32849666</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicosia R.F., Ligresti G., Caporarello N., Akilesh S., Ribatti D. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mecahnism of Endothelial Injury. Am. J. Pathol. 2021;191:1374–1384. doi: 10.1016/j.ajpath.2021.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2021.05.007</ArticleId><ArticleId IdType="pmc">PMC8141344</ArticleId><ArticleId IdType="pubmed">34033751</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T., Levy J.H., Maier C.L., Connors J.M., Levi M. Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: What have we learned? J. Thromb. Haemost. 2024;22:1541–1549. doi: 10.1016/j.jtha.2024.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2024.02.013</ArticleId><ArticleId IdType="pubmed">38428590</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J.L., Francois B., Zabolotskikh I., Daga M.K., Lascarrou J.B., Kirov M.Y., Pettilä V., Wittebole X., Meziani F., Mercier E., et al. Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial. JAMA. 2019;321:1993–2002. doi: 10.1001/jama.2019.5358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.5358</ArticleId><ArticleId IdType="pmc">PMC6547077</ArticleId><ArticleId IdType="pubmed">31104069</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeliger B., Doebler M., Hofmaenner D.A., Wendel-Garcia P.D.M., Schuepbach R.A., Schmidt J.J., Welte T., Hoeper M.M., Gillmann H.-J., Kuehn C., et al. Intracranial Hemorrhages on Extracorporeal Membrane Oxygenation: Differences Between COVID-19 and Other Viral Acute Respiratory Distress Syndrome. Crit. Care Med. 2022;50:e526–e538. doi: 10.1097/CCM.0000000000005441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005441</ArticleId><ArticleId IdType="pmc">PMC9112509</ArticleId><ArticleId IdType="pubmed">35020672</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>